Parexel has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel?s offerings will be combined into the ClinPhone? RTSM suite
Parexel has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel’s offerings will be combined into the ClinPhone® RTSM suite and are designed to make patient randomization and clinical supply chain solutions more efficient. Capabilities include advanced RTSM technologies for planning, forecasting and supply chain eLogistics. The offerings are particularly helpful in accelerating study start-up timelines. The entire ClinPhone® RTSM suite will be available through the Perceptive MyTrials® platform and as a standalone solution, and both solutions will be available through the Perceptive® Partner Program. More information is contained in the full press release.
